SAN JOSE, May 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Pamela D. Garzone, Chief Development Officer of Anixa, will present a poster at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place on May 30 – June 3, 2025, in Chicago, Illinois.

image for news Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Ribbon to Participate in Upcoming Investor Conferences — Neutral

RBBN   PRNewsWire — May 12, 2025

PLANO, Texas , May 12, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a leading supplier of real-time communications technology and IP optical networking solutions, announced that members of its executive team will attend two investor conferences this month. Ribbon is dedicated to assisting the world's largest service providers, enterprises and critical infrastructure operators in modernizing and safeguarding their networks and services.

image for news Ribbon to Participate in Upcoming Investor Conferences

PARSIPPANY, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the first quarter ended March 31, 2025, as well as recent business developments.

image for news Lincoln Educational Services Reports First Quarter Financial Results: Double Digit Growth in Revenue and Student Starts, Increased Outlook for Full Year 2025

GREENWICH, Conn., May 12, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) announced today that it will hold a conference call to discuss its fourth fiscal quarter earnings on Monday, May 19, 2025 at 9:00 AM ET. The toll-free dial-in number is 1-833-470-1428, access code number 818188. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-866-813-9403. The replay pass-code number is 138532.

image for news Oxford Lane Capital Corp. Schedules Fourth Fiscal Quarter Earnings Release and Conference Call for May 19, 2025

ArriVent BioPharma Reports First Quarter 2025 Financial Results — Neutral

AVBP   GlobeNewsWire — May 12, 2025

Completed enrollment in global pivotal Phase 3 study for firmonertinib monotherapy in first-line NSCLC harboring EGFR exon 20 insertion mutations Planned update for development of firmonertinib in first-line NSCLC PACC mutations in Q2 2025 First IND for ARR-217 (MRG007), an antibody drug conjugate (ADC) targeting CDH17, submitted in China Cash, cash equivalents and marketable securities of $205.5 million as of March 31, 2025 NEWTOWN SQUARE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the first …

image for news ArriVent BioPharma Reports First Quarter 2025 Financial Results

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will present at two upcoming scientific conferences: the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, taking place May 13-17, 2025, in New Orleans, Louisiana and the TIDES USA 2025: Oligonucleotide and Peptide Therapeutics Conference, being held May 19-22, 2025, in San Diego, California.

image for news ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that 36-month results from patients enrolled in a Phase 1/2a clinical study (ClinicalTrials.gov Identifier: NCT02286089) of RG6501 (OpRegen) in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD), will be presented at Clinical Trials.

image for news RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025

BRANFORD, Conn.--(BUSINESS WIRE)--Dr. Gloria Sheynkman, University of Virginia, Presents Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Nature Webinar on 5/15.

image for news Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15

We're transforming Alaska's hometown airport into the West Coast's premier global gateway We're planning for at least 12 international destinations with long-haul aircraft from Seattle by 2030 Nonstop transpacific flights between Seattle and Seoul Incheon begin in September SEATTLE , May 12, 2025 /PRNewswire/ -- Alaska Airlines celebrates a new global connection between the Pacific Northwest and Japan with an inaugural flight today between our hometown hub in Seattle and Tokyo Narita, operated by Hawaiian Airlines' long-haul aircraft. The new service marks the start of daily nonstops between the two dynamic cities and the beginning of a new era of …

image for news Alaska Airlines launches new era of widebody international flying in Seattle with daily nonstop service to Tokyo Narita operated by Hawaiian Airlines

Belite Bio to Participate in Four Upcoming Investor Conferences — Neutral

BLTE   GlobeNewsWire — May 12, 2025

SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in four upcoming investor conferences. Details of the presentations are as follows:

image for news Belite Bio to Participate in Four Upcoming Investor Conferences

Trading Symbol: TSX/NYSE American: SVM VANCOUVER, BC , May 12, 2025 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to report an updated independent mineral resource estimate (the "MRE") prepared in accordance with National Instrument 43-101- Standards of Disclosure for Mineral Projects ("NI 43-101") for its Condor gold project in the Zamora-Chinchipe Province of Ecuador (the "Project"). A preliminary economic assessment ("PEA") was completed on the Project in 2021 by a previous operator1, which outlined a high tonnage, low-grade, open pit gold project.

image for news Silvercorp Announces Updated Mineral Resource Estimate for its Condor Project, located in the Zamora Chinchipe Province of Ecuador

RESEARCH TRIANGLE PARK, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders, today announced presentations related to its IRD gene therapy programs at these upcoming scientific conferences in May.

image for news Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May

FREMONT, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the Enphase® IQ® Balcony Solar System in Belgium. Designed for plug-and-play installation, the new system empowers apartment dwellers and homeowners with limited roof space to generate their own clean energy from balconies, patios, and small outdoor areas. It's also a simple and affordable solution for fully off-grid use cases, offering reliable daytime power for cabins, camping sites, mobile home setups, and more. The IQ Balcony Solar …

image for news Enphase Energy Expands in Europe with the IQ Balcony Solar System in Belgium

NORCROSS, Ga., May 12, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, presented a late-breaking oral presentation of the NAVIGATE study analysis at the EASL 2025 Congress, on May 10, 2025, in Amsterdam, Netherlands. The NAVIGATE study evaluated belapectin, a galectin-3 inhibitor, in patients with MASH cirrhosis and portal hypertension.

image for news Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress

- First Quarter Record Sales of $20.3 Million, Up 27%, over Q1 2024 -First Quarter Record Gross Profit of $7.9 Million, Up 30%, over Q1 2024 - First Quarter Positive Adjusted EBITDA HOLLYWOOD, FL, May 12, 2025 (GLOBE NEWSWIRE) -- Healthy Choice Wellness Corp. (NYSE-AM: HCWC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Results Highlights: Net sales from operations for the three-month period ended March 31, 2025, amounted to a record $20.3 million, compared to $15.9 million, an approximate $4.4 million and 27% increase versus the same period in 2024.

image for news Healthy Choice Wellness Corp. Announces Record First Quarter 2025 Financial Results

DETROIT--(BUSINESS WIRE)--Zebra Technologies Corporation, a global leader in digitizing and automating frontline workflows, today announced that it is presenting its newest solutions to advance intelligent automation across manufacturing and warehouse operations. Zebra's portfolio is being showcased in Booth 3207 at Automate 2025 on May 12-15 at Detroit's Huntington Place. “Visibility is the first step to transformation, and the adoption of AI and intelligent automation enables manufacturers an.

image for news Zebra Technologies Showcases New Intelligent Automation Solutions at Automate 2025

JetBlue Runs on Dunkin'® With New Special Livery — Neutral

JBLU   Business Wire — May 12, 2025

BOSTON--(BUSINESS WIRE)--JetBlue (Nasdaq: JBLU) and Dunkin', America's largest coffee and donuts brand, today unveiled a new Dunkin'-themed livery in honor of their longstanding partnership. The vibrant design of the freshly painted Airbus A320 aircraft, appropriately named Brewing Altitude, features Dunkin's iconic pink and orange branding, brought to life with a playful donut and coffee motif. The aircraft's new look was revealed at a celebratory event in Boston where both brands have deep ro.

image for news JetBlue Runs on Dunkin'® With New Special Livery

High Yield, Low Drama: Two 7-10% Yielding Cash Cows On Sale — Positive

BXSL  ET   Seeking Alpha — May 12, 2025

Focusing on downside protection is crucial; unrealized gains can evaporate, making diversified income stocks with meaningful yields essential for retail investors. Blackstone Secured Lending offers a 10.4% yield with a portfolio of first-lien, sponsor-backed loans, a strong balance sheet, and reliable dividend coverage. Energy Transfer provides a 7.6% yield with fee-based midstream operations, strategic infrastructure assets, and well-covered, growing distributions, insulated from commodity price swings.

image for news High Yield, Low Drama: Two 7-10% Yielding Cash Cows On Sale

RAMACO RESOURCES REPORTS FIRST QUARTER 2025 RESULTS — Neutral

METC  METCB   PRNewsWire — May 12, 2025

LEXINGTON, Ky. , May 12, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company"), is a leading operator and developer of high-quality, low-cost metallurgical coal in Central Appalachia and future developer of rare earth and critical minerals in Wyoming.

image for news RAMACO RESOURCES REPORTS FIRST QUARTER 2025 RESULTS

Adtalem Names Megan Noel its New Chief Corporate Affairs Officer — Neutral

ATGE   Business Wire — May 12, 2025

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the United States, has appointed Megan Noel as its Chief Corporate Affairs Officer, effective immediately. Noel will lead Adtalem's corporate affairs function, overseeing communications, investor relations, government relations, impact and alumni engagement, ensuring the company's stakeholder engagement strategy supports its growth strategy. She will be responsible for driving strategic outcomes.

image for news Adtalem Names Megan Noel its New Chief Corporate Affairs Officer